{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:52:52Z","timestamp":1782604372111,"version":"3.54.5"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>The development of cytomegalovirus (CMV) infection after kidney transplant remains a significant cause of posttransplant morbidity, graft loss, and mortality. Despite appropriate antiviral therapy, recipients without previous CMV exposure can currently be allocated a kidney from a donor with previous CMV infection (D+R\u2013) that carries the greatest risk of posttransplant CMV infection and associated complications. Preferential placement of CMV D\u2013 organs in negative recipients (R\u2013) has been shown to reduce the risk of viral infection and associated complications.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>To assess the long-term survival and economic benefits of allocation policy reforms, a decision-analytic model was constructed to compare receipt of CMV D\u2013 with CMV D+ organ in CMV R\u2013 recipients using data from transplant registry, Medicare claims, and pharmaceutical costs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>For CMV R\u2013 patients, receipt of a CMV D\u2013 organ was associated with greater average survival (14.3 versus 12.6 y), superior quality-adjusted life years (12.6 versus 9.8), and lower costs ($529\u2009512 versus $542\u2009963). One-way sensitivity analysis demonstrated a survival advantage for patients waiting as long as 30 mo for a CMV D\u2013 kidney.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>Altering national allocation policy to preferentially offer CMV D\u2013 organs to CMV R\u2013 recipients could improve survival and lower costs after transplant if appropriately implemented.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000003887","type":"journal-article","created":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T20:03:25Z","timestamp":1626293005000},"page":"1227-1232","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":17,"title":["The Clinical and Economic Benefit of CMV Matching in Kidney Transplant: A Decision Analysis"],"prefix":"10.1097","volume":"106","author":[{"given":"David A.","family":"Axelrod","sequence":"first","affiliation":[{"name":"Solid Organ Transplant Center, Department of Surgery, University of Iowa, Iowa City, IA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Hsin","family":"Chang","sequence":"additional","affiliation":[{"name":"Division of Public Health Sciences, Department of Surgery, Washington University in St. Louis School of Medicine, St. Louis, MO."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista L.","family":"Lentine","sequence":"additional","affiliation":[{"name":"Department of Medicine, Saint Louis University, St. Louis, MO."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Schnitzler","sequence":"additional","affiliation":[{"name":"Department of Medicine, Saint Louis University, St. Louis, MO."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doug","family":"Norman","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Oregon Health Sciences University, Portland, OR."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Olyaei","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Oregon Health Sciences University, Portland, OR."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren","family":"Malinoski","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Oregon Health Sciences University, Portland, OR."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Dharnidharka","sequence":"additional","affiliation":[{"name":"Division of Public Health Sciences, Department of Surgery, Washington University in St. Louis School of Medicine, St. Louis, MO."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorry","family":"Segev","sequence":"additional","affiliation":[{"name":"Department of Surgery, Johns Hopkins University, Baltimore, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory R.","family":"Istre","sequence":"additional","affiliation":[{"name":"Injury Prevention Center, Dallas, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph B.","family":"Lockridge","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Medicine, VA Portland Health Care System, Portland, OR."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,7,6]]},"reference":[{"key":"R1-20250604","doi-asserted-by":"crossref","first-page":"e13512","DOI":"10.1111\/ctr.13512","article-title":"Cytomegalovirus in solid organ transplant recipients-Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice.","volume":"33","author":"Razonable","year":"2019","journal-title":"Clin Transplant"},{"key":"R2-20250604","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/ajt.15183","article-title":"Cytomegalovirus mismatch still negatively affects patient and graft survival in the era of routine prophylactic and preemptive therapy: a paired kidney analysis.","volume":"19","author":"Leeaphorn","year":"2019","journal-title":"Am J Transplant"},{"key":"R3-20250604","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/ajt.16132","article-title":"CMV high-risk status and posttransplant outcomes in kidney transplant recipients treated with belatacept.","volume":"21","author":"Karadkhele","year":"2021","journal-title":"Am J Transplant"},{"key":"R4-20250604","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1097\/TP.0000000000000641","article-title":"Impact of cytomegalovirus on long-term mortality and cancer risk after organ transplantation.","volume":"99","author":"Desai","year":"2015","journal-title":"Transplantation"},{"key":"R5-20250604","article-title":"Cost effectiveness of preemptive therapy versus prophylaxis in a randomized clinical trial for the prevention of CMV disease in seronegative liver transplant recipients with seropositive donors.","author":"Singh","journal-title":"Clin Infect Dis"},{"key":"R6-20250604","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1097\/TP.0000000000001338","article-title":"Recurrence of CMV infection and the effect of prolonged antivirals in organ transplant recipients.","volume":"101","author":"Natori","year":"2017","journal-title":"Transplantation"},{"key":"R7-20250604","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1086\/528718","article-title":"Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation.","volume":"46","author":"Arthurs","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R8-20250604","first-page":"1","article-title":"Late cytomegalovirus infection in kidney transplant recipients after a six-month prevention protocol.","volume":"10","author":"Cunha","year":"2019","journal-title":"Int J Organ Transplant Med"},{"key":"R9-20250604","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/jmv.23539","article-title":"High risk of cytomegalovirus infection following solid organ transplantation despite prophylactic therapy.","volume":"85","author":"Harvala","year":"2013","journal-title":"J Med Virol"},{"key":"R10-20250604","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1097\/TP.0b013e3181ff1493","article-title":"Extended valganciclovir prophylaxis in D+\/R- kidney transplant recipients is associated with long-term reduction in cytomegalovirus disease: two-year results of the IMPACT study.","volume":"90","author":"Humar","year":"2010","journal-title":"Transplantation"},{"key":"R11-20250604","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s11908-012-0292-2","article-title":"Cytomegalovirus in solid organ transplantation: epidemiology, prevention, and treatment.","volume":"14","author":"Beam","year":"2012","journal-title":"Curr Infect Dis Rep"},{"key":"R12-20250604","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1399-3062.2010.00533.x","article-title":"Cytomegalovirus risk factors in renal transplantation with modern immunosuppression.","volume":"12","author":"Bataille","year":"2010","journal-title":"Transpl Infect Dis"},{"key":"R13-20250604","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1093\/ajhp\/62.suppl_1.S7","article-title":"Epidemiology of cytomegalovirus disease in solid organ and hematopoietic stem cell transplant recipients.","volume":"62","author":"Razonable","year":"2005","journal-title":"Am J Health Syst Pharm"},{"key":"R14-20250604","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.transproceed.2017.09.058","article-title":"Resistant cytomegalovirus infection after renal transplantation: literature review.","volume":"50","author":"Cintra-Cabrera","year":"2018","journal-title":"Transplant Proc"},{"key":"R15-20250604","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3947\/ic.2013.45.3.260","article-title":"Cytomegalovirus infections in solid organ transplantation: a review.","volume":"45","author":"Ramanan","year":"2013","journal-title":"Infect Chemother"},{"key":"R16-20250604","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1111\/ajt.15976","article-title":"Cytomegalovirus serologic matching in deceased donor kidney allocation optimizes high- and low-risk (D+R- and D-R-) profiles and does not adversely affect transplant rates.","volume":"20","author":"Lockridge","year":"2020","journal-title":"Am J Transplant"},{"issue":"Suppl s1","key":"R17-20250604","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/ajt.15672","article-title":"OPTN\/SRTR 2018 annual data report: kidney.","volume":"20","author":"Hart","year":"2020","journal-title":"Am J Transplant"},{"key":"R18-20250604","doi-asserted-by":"crossref","first-page":"e1001307","DOI":"10.1371\/journal.pmed.1001307","article-title":"A systematic review and meta-analysis of utility-based quality of life in chronic kidney disease treatments.","volume":"9","author":"Wyld","year":"2012","journal-title":"Plos Med"},{"key":"R19-20250604","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/ajt.14018","article-title":"The changing financial landscape of renal transplant practice: a national cohort analysis.","volume":"17","author":"Axelrod","year":"2017","journal-title":"Am J Transplant"},{"key":"R20-20250604","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/ajt.14702","article-title":"An economic assessment of contemporary kidney transplant practice.","volume":"18","author":"Axelrod","year":"2018","journal-title":"Am J Transplant"},{"key":"R21-20250604","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.transproceed.2020.01.028","article-title":"Impact of cytomegalovirus serostatus on allograft loss and mortality within the first year after kidney transplantation: an analysis of the National Transplant Registry.","volume":"52","author":"Bruminhent","year":"2020","journal-title":"Transplant Proc"},{"key":"R22-20250604","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/bmt.2016.352","article-title":"Recipient\/donor HLA and CMV matching in recipients of T-cell-depleted unrelated donor haematopoietic cell transplants.","volume":"52","author":"Shaw","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"R23-20250604","first-page":"CD004759","article-title":"Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients.","volume":"1","author":"Hill","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"R24-20250604","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1111\/ajt.16430","article-title":"Increased incidence and unusual presentations of CMV disease in kidney transplant recipients after conversion to belatacept.","volume":"21","author":"Chavarot","year":"2021","journal-title":"Am J Transplant"},{"key":"R25-20250604","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1523-1755.2004.00735.x","article-title":"Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival.","volume":"66","author":"Sagedal","year":"2004","journal-title":"Kidney Int"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003887","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T19:08:48Z","timestamp":1749064128000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000003887","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]}}}